Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker HRMY
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 35,852 | $43.05 | $1.5M Sale | Form 4 ↗ |
| Sep 17, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 800 | $43.00 | $34.4K Sale | Form 4 ↗ |
| Sep 16, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 1,800 | $43.01 | $77.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 22,954 | $43.10 | $989.3K Sale | Form 4 ↗ |
| Sep 8, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 1,000 | $42.79 | $42.8K Sale | Form 4 ↗ |
| Sep 8, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 4,500 | $42.25 | $190.1K Sale | Form 4 ↗ |
| Sep 4, 2026 | Kumar Budur CHIEF MEDICAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 5,500 | $41.98 | $230.9K Sale | Form 4 ↗ |
| Jan 26, 2026 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 3,746 | $37.15 | $139.2K Sale | Form 4 ↗ |
| Jan 15, 2026 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 20,961 | $35.92 | $752.9K Sale | Form 4 ↗ |
| Dec 12, 2025 | Jeffrey M. Dayno PRESIDENT, CEO, Director | HRMY Harmony Biosciences Holdings, Inc. | Sale | 5,933 | $40.11 | $238.0K Sale | Form 4 ↗ |
| Dec 12, 2025 | Jeffrey M. Dayno PRESIDENT, CEO, Director | HRMY Harmony Biosciences Holdings, Inc. | Sale | 20,000 | $40.11 | $802.2K Sale | Form 4 ↗ |
| Dec 5, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 20,000 | $39.54 | $790.8K Sale | Form 4 ↗ |
| Nov 21, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 3,427 | $35.00 | $119.9K Sale | Form 4 ↗ |
| Aug 15, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 21,573 | $36.50 | $787.4K Sale | Form 4 ↗ |
| Apr 1, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 740 | $33.12 | $24.5K Sale | Form 4 ↗ |
| Apr 1, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 6,247 | $32.48 | $202.9K Sale | Form 4 ↗ |
| Mar 3, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 500 | $33.23 | $16.6K Sale | Form 4 ↗ |
| Mar 3, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 4,369 | $32.61 | $142.5K Sale | Form 4 ↗ |
| Jan 27, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 1,629 | $38.02 | $61.9K Sale | Form 4 ↗ |
| Jan 27, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 1,775 | $38.05 | $67.5K Sale | Form 4 ↗ |
| Jan 24, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 5,125 | $37.87 | $194.1K Sale | Form 4 ↗ |
| Jan 24, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 8,000 | $36.94 | $295.5K Sale | Form 4 ↗ |
| Jan 21, 2025 | Jeffrey M. Dayno PRESIDENT, CEO, Director | HRMY Harmony Biosciences Holdings, Inc. | Sale | 19,293 | $40.13 | $774.2K Sale | Form 4 ↗ |
| Jan 21, 2025 | Sandip Kapadia CHIEF FINANCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 25,000 | $40.18 | $1.0M Sale | Form 4 ↗ |
| Jan 21, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 1,123 | $40.00 | $44.9K Sale | Form 4 ↗ |
| Jan 16, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 29,475 | $37.41 | $1.1M Sale | Form 4 ↗ |
| Jan 15, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 10,507 | $37.01 | $388.9K Sale | Form 4 ↗ |
| Jan 13, 2025 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 7,180 | $37.04 | $265.9K Sale | Form 4 ↗ |
| Nov 5, 2024 | Valor Equity Partners IV-B L.P. 10% owner | HRMY Harmony Biosciences Holdings, Inc. | Sale | 600,000 | $30.30 | $18.2M Sale | Form 4 ↗ |
| Nov 5, 2024 | Marshman Fund Trust II 10% owner | HRMY Harmony Biosciences Holdings, Inc. | Sale | 600,000 | $30.30 | $18.2M Sale | Form 4 ↗ |
| Nov 1, 2024 | Valor Equity Partners IV-B L.P. 10% owner | HRMY Harmony Biosciences Holdings, Inc. | Sale | 4.00M | $30.30 | $121.2M Sale | Form 4 ↗ |
| Nov 1, 2024 | Marshman Fund Trust II 10% owner | HRMY Harmony Biosciences Holdings, Inc. | Sale | 4.00M | $30.30 | $121.2M Sale | Form 4 ↗ |
| Oct 29, 2024 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 21,496 | $40.47 | $869.9K Sale | Form 4 ↗ |
| Oct 3, 2024 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 705 | $35.62 | $25.1K Sale | Form 4 ↗ |
| Oct 3, 2024 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 35,652 | $35.05 | $1.2M Sale | Form 4 ↗ |
| Oct 1, 2024 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 400 | $40.19 | $16.1K Sale | Form 4 ↗ |
| Sep 30, 2024 | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | HRMY Harmony Biosciences Holdings, Inc. | Sale | 35,846 | $40.03 | $1.4M Sale | Form 4 ↗ |
37 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:00 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances